Skip to content
Search

Latest Stories

Former NPA director Phil Galt named new Cegedim Rx UK managing director

Former NPA director Phil Galt named new Cegedim Rx UK managing director

Phill Galt replaces Adam Dennett who stepped down from the Cegedim Rx's leadership role after a successful ten-year tenure 

Former superintendent pharmacist and National Pharmacy Association (NPA) director, Phil Galt, has been appointed the new UK managing director for pharmacy software supplier Cegedim Rx.


The position was previously held by Adam Dennett, who resigned after a successful ten-year tenure to pursue a new career outside healthcare, the company said.

Cegedim Rx, the pharmacy entity of Cegedim Healthcare Solutions UK, announced the new appointment this month (April 5).

Tristan de Foucher, head of European operations for Cegedim Group, said: “Adam has been a force of nature in this business for the past 10 years. Under his leadership, the team has continuously and successfully invested in and driven product innovation to stay ahead of the ever-changing demands placed upon community pharmacy.”

Galt has over 20 years of experience as a qualified pharmacist and a successful business leader. He has worked extensively in community pharmacy, focusing on both care delivery and technology implementation.

More recently, Galt simultaneously served as the managing director and superintendent pharmacist for Lindsay & Gilmour Pharmacy, an independent chain comprising 32 locations.

Previously, he held positions as a non-executive director on the board of the National Pharmacy Association Insurance Company (NPAI) and as a director of the Association of Independent Multiple Pharmacies (AIMp).

Galt also served as a trustee for the NPA Health Education Foundation, a charity set up to advance public education in the prevention and proper treatment of disease by encouraging greater research within community pharmacy.

Commenting on his appointment, Phil said: “I know the pressures of delivering frontline care in community pharmacy and just how challenging it can be to juggle this alongside managing a sustainable and profitable business.

“I’m therefore truly looking forward to bringing Cegedim Rx my 20 years of customer experience and industry expertise in order to accelerate the company’s product innovation and revenue growth.”

Foucher expressed his delight in having someone of Galt's caliber and industry experience join the company

“Phil Galt is an industry visionary with a proven track record of execution.

“It is an exciting moment in the life of Cegedim Rx and we welcome his leadership to federate the team behind his expertise, enable enhanced support to pharmacists and deliver better patient outcomes,”  he said.

Cegedim Rx offers a comprehensive suite of pharmacy software solutions, including PMR system Pharmacy Manager, Pharmacy Services and Pharmacy Intelligence Hub.

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less